| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Liabilities Shareholders' Equity | 3,411.45 | 2,850.41 | 2,702.15 | 2,471.01 |
| Accumulated Depreciation Total | -253.73 | -199.36 | -151.62 | -112.99 |
| Cash Equivalents | 25.02 | 269.60 | 228.06 | 490.11 |
| Other Liabilities Total | 18.54 | 15.77 | 7.87 | - |
| Accrued Expenses | 34.28 | 28.43 | 8.38 | 42.06 |
| Common Stock Total | 24.51 | 24.51 | 24.51 | 24.51 |
| Other Current Assets Total | 0.30 | 0.70 | 26.22 | 20.81 |
| Prepaid Expenses | 2.26 | 0.81 | 0.14 | 0.16 |
| Total Assets | 3,411.45 | 2,850.41 | 2,702.15 | 2,471.01 |
| Current Portof LT Debt/ Capital Leases | 5.65 | 2.39 | 2.26 | 1.68 |
| Additional Paid- In Capital | 1,005.72 | 1,004.96 | 1,004.96 | 1,004.96 |
| Cash | 46.04 | 31.82 | 55.76 | 22.05 |
| Total Equity | 2,817.37 | 2,332.32 | 2,138.21 | 2,054.31 |
| Long Term Investments | 0.08 | 0.08 | 0.08 | 5.64 |
| Retained Earnings( Accumulated Deficit) | 1,787.15 | 1,302.86 | 1,108.75 | 1,024.85 |
| Total Common Shares Outstanding | 12.25 | 12.25 | 12.25 | 12.25 |
| Property/ Plant/ Equipment Total- Gross | 1,290.65 | 1,095.56 | 975.87 | 789.32 |
| Tangible Book Valueper Share Common Eq | 228.31 | 189.14 | 173.04 | 166.81 |
| Total Liabilities | 594.08 | 518.09 | 563.94 | 416.70 |
| Total Debt | 56.61 | 17.15 | 19.36 | 2.88 |
| Short Term Investments | 477.61 | - | - | - |
| Cashand Short Term Investments | 548.68 | 301.41 | 283.82 | 512.16 |
| Total Receivables Net | 1,101.72 | 931.95 | 918.31 | 715.21 |
| Notes Payable/ Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Income Tax | 54.43 | 48.79 | 42.43 | 31.49 |
| Accounts Receivable- Trade Net | 969.74 | 765.43 | 806.77 | 673.49 |
| Property/ Plant/ Equipment Total- Net | 1,036.92 | 896.20 | 824.24 | 676.34 |
| Total Current Liabilities | 470.16 | 438.77 | 496.54 | 384.00 |
| Total Inventory | 682.20 | 681.13 | 621.86 | 516.24 |
| Accounts Payable | 390.46 | 368.66 | 427.23 | 307.72 |
| Other Currentliabilities Total | 39.77 | 39.30 | 58.68 | 32.54 |
| Total Long Term Debt | 50.96 | 14.76 | 17.09 | 1.20 |
| Intangibles Net | 19.94 | 14.85 | 18.00 | 10.38 |
| Other Long Term Assets Total | 6.37 | 11.03 | 8.21 | 14.07 |
| Note Receivable- Long Term | 12.99 | 12.26 | 1.27 | 0.00 |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 2,335.16 | 1,916.00 | 1,850.34 | 1,764.58 |
| Capital Lease Obligations | 50.96 | 14.76 | 17.09 | 1.20 |
Alivus Life Sciences Dividend Alivus Life Sciences Bonus Alivus Life Sciences News Alivus Life Sciences AGM Alivus Life Sciences Rights Alivus Life Sciences Splits Alivus Life Sciences Board Meetings Alivus Life Sciences Key Metrics Alivus Life Sciences Shareholdings Alivus Life Sciences Profit Loss Alivus Life Sciences Cashflow Alivus Life Sciences Q1 Results Alivus Life Sciences Q2 Results Alivus Life Sciences Q3 Results Alivus Life Sciences Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks